Next Article in Journal
In Silico Screening Identifies a Novel Potential PARP1 Inhibitor Targeting Synthetic Lethality in Cancer Treatment
Next Article in Special Issue
Chemical Elicitor-Induced Modulation of Antioxidant Metabolism and Enhancement of Secondary Metabolite Accumulation in Cell Suspension Cultures of Scrophularia kakudensis Franch
Previous Article in Journal
Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells
Previous Article in Special Issue
Cissus sicyoides: Pharmacological Mechanisms Involved in the Anti-Inflammatory and Antidiarrheal Activities
Article

Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells

1
Institute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University, Iksan 570–749, Korea
2
Institute of Marine Biochemistry, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Caugiay, Hanoi 10000, Vietnam
*
Author to whom correspondence should be addressed.
These authors contributed equally to this study.
Academic Editor: Chang Won Choi
Int. J. Mol. Sci. 2016, 17(2), 255; https://doi.org/10.3390/ijms17020255
Received: 8 December 2015 / Revised: 12 January 2016 / Accepted: 5 February 2016 / Published: 19 February 2016
(This article belongs to the Special Issue Plant-Derived Pharmaceuticals by Molecular Farming 2016)
In Korea and China, Cudrania tricuspidata Bureau (Moraceae) is an important traditional medicinal plant used to treat lumbago, hemoptysis, and contusions. The C. tricuspidata methanol extract suppressed both production of NO and PGE2 in BV2 microglial cells. Cudraflavanone D (1), isolated from this extract, remarkably suppressed the protein expression of inducible NO synthase and cyclooxygenase-2, and decreased the levels of NO and PGE2 in BV2 microglial cells exposed to lipopolysaccharide. Cudraflavanone D (1) also decreased IL-6, TNF-α, IL-12, and IL-1β production, blocked nuclear translocation of NF-κB heterodimers (p50 and p65) by interrupting the degradation and phosphorylation of inhibitor of IκB-α, and inhibited NF-κB binding. In addition, cudraflavanone D (1) suppressed the phosphorylation of c-Jun N-terminal kinase (JNK) and p38 MAPK pathways. This study indicated that cudraflavanone D (1) can be a potential drug candidate for the cure of neuroinflammation. View Full-Text
Keywords: Cudrania tricuspidata; cudraflavanone D; microglia; neuroinflammation; nuclear factor-κB; mitogen-activated protein kinase Cudrania tricuspidata; cudraflavanone D; microglia; neuroinflammation; nuclear factor-κB; mitogen-activated protein kinase
Show Figures

Graphical abstract

MDPI and ACS Style

Kim, D.-C.; Yoon, C.-S.; Quang, T.H.; Ko, W.; Kim, J.-S.; Oh, H.; Kim, Y.-C. Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells. Int. J. Mol. Sci. 2016, 17, 255. https://doi.org/10.3390/ijms17020255

AMA Style

Kim D-C, Yoon C-S, Quang TH, Ko W, Kim J-S, Oh H, Kim Y-C. Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells. International Journal of Molecular Sciences. 2016; 17(2):255. https://doi.org/10.3390/ijms17020255

Chicago/Turabian Style

Kim, Dong-Cheol, Chi-Su Yoon, Tran H. Quang, Wonmin Ko, Jong-Su Kim, Hyuncheol Oh, and Youn-Chul Kim. 2016. "Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells" International Journal of Molecular Sciences 17, no. 2: 255. https://doi.org/10.3390/ijms17020255

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop